Source: Eur Respir J, 50 (2) 1700422; 10.1183/13993003.00422-2017



Rating:

Share or cite this content

Citations should be made in the following way:
Markus Glatzer, Achim Rittmeyer, Joachim Müller, Isabelle Opitz, Alexandros Papachristofilou, Ioannis Psallidas, Martin Früh, Diana Born, Paul Martin Putora. Treatment of limited disease small cell lung cancer: the multidisciplinary team. Eur Respir J, 50 (2) 1700422; 10.1183/13993003.00422-2017

Member's Comments

No comment yet.

Related content which might interest you: Managing the initial treatment and multiple relapses in a small cell lung cancer patient with limited disease Source: International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care Year: 2018 Surgical management of patients with small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001 Direct to surgery treatment of suspected lung cancer – results from a UK lung cancer multidisciplinary team (MDT) Source: Virtual Congress 2021 – Innovation in thoracic surgery Year: 2021 Radiotherapy in small cell lung cancer: patient options Source: Virtual Congress 2020 – Thoracic oncology Year: 2020 Treatment of extensive-stage small cell lung carcinoma: current status and future prospects Source: Eur Respir J 2010; 35: 202-215 Year: 2010 No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team Source: Eur Respir J 2009; 33: 941-942 Year: 2009 Update on small cell lung cancer management Source: Breathe 2012; 8: 315-330 Year: 2012 The effectiveness of a multidisciplinary approach in the management of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 495s Year: 2005 Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC) Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Surgical treatment of small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 172s Year: 2005 Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer (ED SCLC) Source: International Congress 2019 – Treatment of lung cancer Year: 2019 The characterisation of interstitial lung disease multidisciplinary team meetings: a global study Source: ERJ Open Res, 5 (2) 00209-2018; 10.1183/23120541.00209-2018 Year: 2019 Surgery for non small cell lung cancer (NSCLC) and functional limits: is there a possible beneficial role of preoperative pulmonary rehabilitation? Source: Eur Respir J 2004; 24: Suppl. 48, 522s Year: 2004 Exploring patient perceptions of their COPD or lung cancer multidisciplinary team Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 New treatment concepts in stage IV non-small cell lung cancer: personalised multidisciplinary approaches Source: Virtual Congress 2021 – Thoracic oncology Year: 2021 Curative treatment vs. best supportive care in advanced non small cell lung cancer in aged person Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 A comparison of patients from a regional multi disciplinary team referred for surgical lung cancer treatment Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017 Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group Source: Eur Respir J 2005; 26: Suppl. 49, 500s Year: 2005